Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(1)
Other(3)

Detailed Status

unknown3
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting120%
unknown360%
completed120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

Impact of CMG vs VCMG in Recurrent Stress Incontinence- A Pilot Study

NCT07542080
unknown

Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies

NCT04738539
unknown

Urodynamic Evaluation in Patients After Spinal Cord Injury

NCT04231474
unknown

Comprehensive Study on the Quality of Life in Cervical Cancer Patients

NCT03967457
completed

Sensory Sensitivity and Urinary Symptoms in the Female Population

NCT01978002

Clinical Trials (5)

Showing 5 of 5 trials
NCT07542080Not Applicable

Impact of CMG vs VCMG in Recurrent Stress Incontinence- A Pilot Study

Recruiting
NCT04738539

Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies

Unknown
NCT04231474

Urodynamic Evaluation in Patients After Spinal Cord Injury

Unknown
NCT03967457

Comprehensive Study on the Quality of Life in Cervical Cancer Patients

Unknown
NCT01978002

Sensory Sensitivity and Urinary Symptoms in the Female Population

Completed

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5